The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Humoral Immune Response in Acute Hepatitis C Virus Infection
Abstract
BACKGROUND: There is little information on the timing, magnitude, specificity, and clinical relevance of the antibody response to acute hepatitis C virus (HCV) infection. We investigated the specificity, titer, and neutralizing potential of antibody responses to acute infection by examining 12 injection drug users before, during, and after infection. METHODS: Seroconversion was defined as incident detection of HCV-specific antibodies by using a commercially available enzyme-linked immuosorbent assay (ELISA). HCV protein-specific antibody responses were measured using recombinant antigens in an ELISA. For neutralization assays, plasma was incubated with human immunodeficiency virus (HIV)-HCV H77 or control HIV-murine leukemia virus (MLV) pseudotype virus and then allowed to infect Hep3B hepatoma cells. RESULTS: The mean time to HCV seroconversion was 6 weeks after the onset of viremia. Antibody responses to nonstructural proteins were detected before responses to the structural proteins, and antibodies to both were primarily restricted to the immunoglobulin G1 (IgG1) subclass. The maximum median end point titers for antibody responses to structural and nonstructural proteins were 1 : 600 and 1 : 6400, respectively. Antibodies that neutralized a retroviral pseudotype bearing HCV 1a envelope glycoproteins were detected at seroconversion in only 1 subject and at 6-8 months after seroconversion in 3 subjects. The delayed appearance of neutralizing antibodies was consistent with the late development of antibodies specific for the viral envelope glycoproteins, which are believed to mediate virus neutralization. CONCLUSION: The humoral immune response to acute HCV infection is of relatively low titer, is restricted primarily to the IgG1 subclass, and is delayed. A better understanding of why production of neutralizing antibody is delayed may improve efforts to prevent HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
Farci, P., Alter, H. J., Wong, D., Miller, R. H., Shih, J. W., Jett, B., & Purcell, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250205 · Cited by 571
Cited by
The immunological life cycle of tuberculosis
Ernst, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3259 · Cited by 577
von Hahn, T., Yoon, J. C., Alter, H., Rice, C. M., Rehermann, B., Balfe, P., & McKeating, J. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.008 · Cited by 425
Self-citationYi, M., Villanueva, R. A., Thomas, D. L., Wakita, T., & Lemon, S. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510727103 · Cited by 357
Self-citationFlying Under the Radar: The Immunobiology of Hepatitis C
Dustin, L. B., & Rice, C. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141602 · Cited by 313
Harker, J. A., Lewis, G. M., Mack, L., & Zuniga, E. I. (2011) · Science · doi:10.1126/science.1208421 · Cited by 311
Metadata
- Authors
- Netski, D. M., Mosbruger, T., Depla, E., Maertens, G., Ray, S. C., Hamilton, R. G., Roundtree, S., Thomas, D. L., McKeating, J., & Cox, A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 41
- Issue
- 5
- Pages
- 667-675
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126482091
- Cited by
- 190
- References
- 1
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Humoral Immune Response in Acute Hepatitis C Virus Infection. https://app.cochat.ai/papers/10.1086/432478
- The paper
- Netski, D. M., Mosbruger, T., Depla, E., Maertens, G., Ray, S. C., Hamilton, R. G., Roundtree, S., Thomas, D. L., McKeating, J., & Cox, A. (2005). Humoral Immune Response in Acute Hepatitis C Virus Infection. Clinical Infectious Diseases. https://doi.org/10.1086/432478
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.